Addressing the significant threat to global health posed by current and future pathogens is a critical unmet need laid bare by the ongoing pandemic. Both traditional and emerging approaches to creating vaccines have limitations, and new options are urgently required. Solaris is applying a technology previously used for inactivating pathogens in the blood supply to rapidly produce safe and effective vaccines against viruses, bacteria and parasites under the trade name SolaVAX™.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Fort Collins, Co 80524, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://solarisvax.com/
- HQ
- Fort Collins, CO
Solaris Vaccines Questions
Solaris Vaccines's website is https://solarisvax.com/
Solaris Vaccines's LinkedIn profile is https://www.linkedin.com/company/solaris-vaccines
Solaris Vaccines has
3 employees.
View email and phone details for 3
employees at Solaris Vaccines.
Solaris Vaccines's industry is
Biotechnology Research
Solaris Vaccines's top competitors are
Rapport Therapeutics,
I-Seq Biotechnology,
Vic Tech,
Benevira,
Azimuth Biologics, Inc,
Erythrocure,
Invenux, Inc.,
Neurexis Therapeutics,
Biotect Services, Inc.,
Castlevax.
Solaris Vaccines's categories are Biotechnology Research
Solaris Vaccines's founding year is 2021
